深圳市海王英特龙生物技术股份有限公司（股票代码：08329）于2026年5月4日发布了2026年4月股份变动月报。公告显示，截至2026年4月30日，公司注册股本为人民币42,600,000元，对应股本总数为426,000,000股普通股（H股）及1,252,000,000股内资股，报告期内未发生任何增资、减资、股份回购或注销，以及用于库存的股份变动。
公告披露，2026年4月底，海王英特龙已发行的H股股份数量为426,000,000股、内资股为1,252,000,000股，合计1,678,000,000股，较上个月保持不变。公司确认已满足香港联交所相关上市规则要求，报告期不存在发行新股、股份购回或回购后待注销情况，亦无可转换债券、公司购股权和其他认股权证的发行或变动事宜。
公告最终由卓佳证券登记有限公司以H股股份过户及登记处名义提交。公司表示将继续严格遵守香港联交所《上市规则》及相关法律法规，保持合规经营并保障股东权益。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.